205 related articles for article (PubMed ID: 27508196)
1. Emerging role of Hpo signaling and YAP in hepatocellular carcinoma.
Valero V; Pawlik TM; Anders RA
J Hepatocell Carcinoma; 2015; 2():69-78. PubMed ID: 27508196
[TBL] [Abstract][Full Text] [Related]
2. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
3. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.
Zhang N; Bai H; David KK; Dong J; Zheng Y; Cai J; Giovannini M; Liu P; Anders RA; Pan D
Dev Cell; 2010 Jul; 19(1):27-38. PubMed ID: 20643348
[TBL] [Abstract][Full Text] [Related]
4. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
Cho YS; Jiang J
Front Cell Dev Biol; 2021; 9():658481. PubMed ID: 33869224
[TBL] [Abstract][Full Text] [Related]
5. The hippo-yes association protein pathway in liver cancer.
Jie L; Fan W; Weiqi D; Yingqun Z; Ling X; Miao S; Ping C; Chuanyong G
Gastroenterol Res Pract; 2013; 2013():187070. PubMed ID: 23986776
[TBL] [Abstract][Full Text] [Related]
6. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
7. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
8. Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma.
Shi H; Zou Y; Wang X; Wang G; Gao Y; Yi F; Xu J; Yin Y; Li D; Li M
Discov Oncol; 2023 May; 14(1):83. PubMed ID: 37243813
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K.
Cho YS; Zhu J; Li S; Wang B; Han Y; Jiang J
Nat Commun; 2018 Apr; 9(1):1657. PubMed ID: 29695716
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.
Hyun J; Al Abo M; Dutta RK; Oh SH; Xiang K; Zhou X; Maeso-Díaz R; Caffrey R; Sanyal AJ; Freedman JA; Patierno SR; Moylan CA; Abdelmalek MF; Diehl AM
J Hepatol; 2021 Sep; 75(3):623-633. PubMed ID: 33964370
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma.
Cho Y; Park MJ; Kim K; Kim SW; Kim W; Oh S; Lee JH
World J Gastroenterol; 2020 Nov; 26(42):6599-6613. PubMed ID: 33268949
[TBL] [Abstract][Full Text] [Related]
12. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma.
Shan L; Jiang H; Ma L; Yu Y
Oncol Lett; 2017 Sep; 14(3):3291-3296. PubMed ID: 28927078
[TBL] [Abstract][Full Text] [Related]
14. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.
Lam-Himlin DM; Daniels JA; Gayyed MF; Dong J; Maitra A; Pan D; Montgomery EA; Anders RA
Int J Gastrointest Cancer; 2006; 37(4):103-9. PubMed ID: 18175224
[TBL] [Abstract][Full Text] [Related]
15. The Roles of NDR Protein Kinases in Hippo Signalling.
Hergovich A
Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.
Wang X; Wu B; Zhong Z
Oncol Lett; 2018 Jul; 16(1):585-593. PubMed ID: 29928445
[TBL] [Abstract][Full Text] [Related]
17. α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells
Chen T; Sun D; Wang Q; Zhou T; Tan J; Xu C; Cheng H; Shen W
Front Oncol; 2022; 12():839603. PubMed ID: 35311132
[TBL] [Abstract][Full Text] [Related]
18. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo.
Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS
Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732
[TBL] [Abstract][Full Text] [Related]
19. ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.
Zhao X; Qin W; Jiang Y; Yang Z; Yuan B; Dai R; Shen H; Chen Y; Fu J; Wang H
NPJ Precis Oncol; 2020; 4():7. PubMed ID: 32219176
[TBL] [Abstract][Full Text] [Related]
20. [Research advances in the role of the Hippo signaling pathway in pathogenesis of liver cancer].
Yuan L; Li ZW
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):797-800. PubMed ID: 29108216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
